Logo image
Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes
Journal article   Open access   Peer reviewed

Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes

Heidi M Harmon, Erik A Jensen, Sylvia Tan, Aasma S Chaudhary, Jonathan L Slaughter, Edward F Bell, Myra H Wyckoff, Angelita M Hensman, Gregory M Sokol, Sara B DeMauro, …
Journal of perinatology, Vol.40(4), pp.616-627
04/2020
DOI: 10.1038/s41372-020-0594-4
PMCID: PMC7101070
PMID: 32020038
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7101070View
Open Access

Abstract

To determine the associations between age at first postnatal corticosteroids (PNS) exposure and risk for severe bronchopulmonary dysplasia (BPD) and neurodevelopmental impairment (NDI). Cohort study of 951 infants born <27 weeks gestational age at NICHD Neonatal Research Network sites who received PNS between 8 days of life (DOL) and 36 weeks' postmenstrual age was used to produce adjusted odds ratios (aOR). Compared with infants in the reference group (22-28 DOL-lowest rate), aOR for severe BPD was similar for children given PNS between DOL 8 and 49 but higher among infants treated at DOL 50-63 (aOR 1.77, 95% CI 1.03-3.06), and at DOL ≥64 (aOR 3.06, 95% CI 1.44-6.48). The aOR for NDI did not vary significantly by age of PNS exposure. For infants at high risk of BPD, initial PNS should be considered prior to 50 DOL for the lowest associated odds of severe BPD.
Age Factors Bronchopulmonary Dysplasia - classification Bronchopulmonary Dysplasia - drug therapy Bronchopulmonary Dysplasia - prevention & control Cohort Studies Dexamethasone - administration & dosage Dexamethasone - adverse effects Drug Administration Schedule Female Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Humans Infant Infant Death Infant, Extremely Premature Infant, Newborn Logistic Models Male Neurodevelopmental Disorders - chemically induced Odds Ratio Patient Acuity Perinatal Death Respiratory Distress Syndrome, Newborn - drug therapy Retrospective Studies

Details

Logo image